• Preserving Cardiac Phosphorylation for Translation

  2026-08-22

  A thought-leadership guide to protecting phosphorylation states in pressure-overload heart-failure research, using the Mac-1 remodeling study to show why phosphatase control is essential for mechanistic confidence and translational reproducibility.

• Baicalin Restores Adult Visual Plasticity in Amblyopia

  2026-08-21

  A 2026 NeuroImage study reports that Baicalin reactivates ocular dominance plasticity in adult amblyopic mice when combined with reverse suturing, restoring cortical eye preference and visual acuity. Imaging, electrophysiology, GAD65/67 and perineuronal-net analyses, and muscimol blockade implicate reduced GABAergic inhibition as an important mechanism, while also defining a dose-dependent experimental response.

• ROS-Responsive LNPs for Mutant RAS mRNA Delivery

  2026-08-20

  Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids to improve the preferential delivery of mRNA into tumor cells. Their lead formulation, BAmP-TK-12, delivered DUF5 mRNA to cleave mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported models.

• DMXAA (Vadimezan): Reliable Cancer Assays

  2026-08-20

  A scenario-based guide to using DMXAA (Vadimezan), SKU A8233, in viability, apoptosis, endothelial, and NSCLC experiments. It connects mechanism, solvent handling, dose selection, orthogonal readouts, and vendor evaluation to improve interpretation and workflow consistency.

• Verbascoside for Reliable PKC/NF-κB Assays

  2026-08-19

  Learn how Verbascoside, SKU B3379, can improve the interpretability of cell viability, cytotoxicity, and RANKL-induced osteoclast differentiation assays. This scenario-based guide covers solvent compatibility, dose selection, pathway controls, data interpretation, and practical vendor evaluation.

• Pyridostigmine and Placental Necroptosis in Preeclampsia

  2026-08-19

  The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and shows that pyridostigmine improves disease-associated outcomes in a rat ischemia model. Pharmacological blockade with α-bungarotoxin links these effects to α7 nicotinic acetylcholine receptor signaling, providing a useful mechanistic framework for studying cholinergic control of placental inflammation and trophoblast injury.

• EZ Cap™ Firefly Luciferase mRNA: 5 Lab Scenarios

  2026-08-18

  Five practical laboratory scenarios show how EZ Cap™ Firefly Luciferase mRNA, SKU R1018, can support controlled reporter expression, delivery optimization, and more defensible viability or cytotoxicity measurements. The guidance separates product specifications from formulation-dependent variables and highlights limitations when translating in vitro results to in vivo bioluminescence imaging.

• AT-406 (SM-406): Reliable Apoptosis Assays

  2026-08-18

  A scenario-based guide to using AT-406 (SM-406), SKU A3019, in cell viability, cytotoxicity, and apoptosis studies. It connects concentration, solvent, Western blot, combination-treatment, interpretation, and supplier-selection decisions to documented product data and current apoptosis research.

• Stattic: A Mechanism-First Guide to STAT3 Research

  2026-08-17

  Stattic is a selective STAT3 inhibitor for dissecting signaling, transcriptional control, and treatment response. This mechanism-first guide connects HNSCC evidence with a lymphatic endothelial study to show how assay design can distinguish STAT3 dependence from nonspecific cellular injury.

• HSP90–METTL3 Control of MYC m6A in Colorectal Cancer

  2026-08-17

  The reference study identifies METTL3 as an HSP90 client protein whose stability links chaperone activity to MYC mRNA m6A modification in colorectal cancer. By combining HSP90 inhibition, ubiquitination and RNA analyses, and pharmacological rescue experiments, it defines an HSP90–METTL3–MYC axis that may help explain how 17-AAG suppresses malignant cell behavior.

• When Hemidystonia Mimics Acute Ischemic Stroke

  2026-08-16

  This case report describes prochlorperazine-induced hemidystonia in a pregnant patient whose sudden unilateral weakness and dysarthria triggered an acute stroke response. The rapid response to intravenous diphenhydramine, medication-history review, serial neurological examinations, and negative MRI illustrate how identifying a stroke mimic can prevent diagnostic anchoring while preserving urgent stroke evaluation.

• Whole-Blood Stimulation for Immunometabolism

  2026-08-15

  Zhao and colleagues present a standardized fresh whole-blood stimulation protocol that combines immune challenges with targeted metabolic interventions. The workflow links cytokine profiling to pathway perturbation, providing a reproducible framework for studying how anabolic and catabolic metabolism shapes human immune responses.

• Baricitinib: Reliable JAK1/2 Assay Design

  2026-08-15

  A scenario-based guide to using Baricitinib (LY3009104, INCB028050), SKU A4141, in cell viability, proliferation, and pathway assays. It connects JAK1/2 pharmacology with practical controls, DMSO handling, concentration selection, and interpretation of STAT3 and cytokine-response data.

• DRB as a Precision Tool for RNA Elongation Biology

  2026-08-14

  Explore how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) separates transcriptional supply from RNA stability and translation in ac4C-regulated stem-cell research. This guide connects CDK-dependent RNA polymerase II control with practical assay design, HIV transcription inhibition, and antiviral research.

• PTT and CD47 Blockade in Oral Cancer

  2026-08-14

  A 2026 study shows that photothermal therapy can overcome two major barriers to CD47-based macrophage therapy in oral squamous cell carcinoma: insufficient eat me signaling and poor immune-cell access. By inducing calreticulin exposure, releasing immunogenic danger signals, and remodeling the tumor extracellular matrix, photothermal therapy substantially improved macrophage phagocytosis and tumor control when combined with CD47 blockade.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page